Medical Progress Today
mpt home | sign up

Volume 2, Number 40
November 4, 2005


PRINTER FRIENDLY

In the Spotlight

Head-to-Head Drug Trials at California's Ballot Box

John R. Graham, Medical Progress Today, 11-3-05

On November 8, Californians will enjoy a rare opportunity to influence the price of prescription drugs in the Golden State. Both Propositions 78 and 79 aim to lower prescription prices for needy Californians. The measures offer starkly different visions of the appropriate relationships between patients, the state, and drug makers. One of them is a step forward, and the other is a step back.
Continue reading . . .

News

Bird flu plan targets unknown: Bush maps assault on disease peril that hasnít yet emerged
Chicago Tribune, 11-5-05

Editorís Notes:

The President has delivered a bold and far-reaching plan to ward off mass casualties in the event of a bird flu pandemic.
Continue reading . . .

Researchers Aim to Stretch Flu-Vaccine Supply
Wall Street Journal, 11-2-05

Editorís Notes:

One popular business clichť holds that the Chinese word for crisis contains two characters: one signaling danger, the other opportunity. Whether the etymology holds up, the moral is true: in times of crisis, people often invent new methods or tactics that were unused until then.
Continue reading . . .

Bush seeking to protect vaccine manufacturers from lawsuits
Associated Press Newswires, 11-1-05

Editorís Notes:

For decades, litigation has hobbled the vaccine industry and slowed the creation of innovative new medical products. The President, nonetheless, is already drawing criticism from some consumer groups and plaintiffís lawyers for his proposal to expand liability protections for vaccine manufacturers.
Continue reading . . .

AIDS gel on a faster track; Merck, Bristol to License Drugs Free for Use in Poor Countries
Washington Post, 11-1-05

Editorís Notes:

Heterosexual transmission of AIDS is the main avenue of infection in Africa, due at least in part to womenís low-social status in many countries there. Researchers, consequently, are searching for products that women can use to protect themselves from AIDS without having to inform their partners.
Continue reading . . .

BIO Files Lawsuit Against DC Over Pending Price Control Bill
BioWorld Online, 10-31-05

Editorís Notes:

Price controls lower supply by choking off incentives to bring new products on the market. Ultimately, price controls hurt consumers at least as much as they hurt producers. That hasnít, however, stopped policymakers in places like Washington, D.C., from trying to push price controls onto the (now unpopular) pharmaceutical industry.
Continue reading . . .

Doctorís Bold Step Paid Off For His Patients
Seattle Post-Intelligencer, 10-31-05

Editorís Notes:

This article shows how one physician and his breast cancer patient took a gamble on an off-label course of cancer treatment that was later validated by research.
Continue reading . . .

Commentary

Early comments on Humeston defense verdict
Ted Frank, PointofLaw.com, 11-3-05

Our sister Web site, Point of Law, is running an ongoing (and always interesting) analysis of Vioxx litigation, including the recent New Jersey verdict in Merckís favor.
Continue reading . . .

Patent Nonsense on avian flu
Alec van Gelder, The Boston Globe, 10-31-05

Gelder reminds us that the policymakers who feel the urge to do something about avian flu by threatening Rocheís patent for Tamiflu may be doing worst thing under the circumstances.
Continue reading . . .

In Control of My Health
David Gratzer, New York Sun, 10-28-05

Gratzer, a senior fellow at the Manhattan Institute, argues that what Medicaid needs is not a tune-up but a comprehensive overhaul. Thankfully, there are promising state initiatives in places like Colorado, Florida, and South Carolina that are doing just this.
Continue reading . . .

Baby Steps: Congressional Action on Medicaid Reform
Nina Owcharenko, Heritage Foundation, 10-27-05

Owcharenko argues that while Congress is poised to make ďmodest administrative changesĒ to Medicaid in the name of budget balancing, what the program really needs is fundamental reform.
Continue reading . . .

The Effect of State Regulations on Health Insurance Premiums: A Preliminary Analysis
Michael New, Heritage Foundation, 10-27-05

Michael New points out that while many state and federal policymakers decry the growing numbers of Americans without consistent access to affordable health insurance, they ignore evidence that ďgovernment policy, particularly excessive regulatory intervention, may price many Americans out of coverage and thus contribute to the high numbers of uninsured.Ē
Continue reading . . .

Research

Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
Tomas Philipson, Ernst R. Berndt, NBER, 11-3-05

Even before Vioxx became a hot-button political issue, a fierce debate raged as to whether one critical FDA reform has hurt public health by expediting the approval of too many unsafe drugs.
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

In this week's issue:

SPOTLIGHT

Head-to-Head Drug Trials at California's Ballot Box

NEWS

Bird flu plan targets unknown: Bush maps assault on disease peril that hasnít yet emerged
Researchers Aim to Stretch Flu-Vaccine Supply
Bush seeking to protect vaccine manufacturers from lawsuits
AIDS gel on a faster track; Merck, Bristol to License Drugs Free for Use in Poor Countries
BIO Files Lawsuit Against DC Over Pending Price Control Bill
Doctorís Bold Step Paid Off For His Patients

COMMENTARY

Early comments on Humeston defense verdict
Patent Nonsense on avian flu
In Control of My Health
Baby Steps: Congressional Action on Medicaid Reform
The Effect of State Regulations on Health Insurance Premiums: A Preliminary Analysis

RESEARCH

Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org